When it was announced that Nintendo was going to be released a fighting game with motion controls called Arms, many were concerned that the response wouldn’t be up to par. Based on early impressions, however, both the game and the controls seem to be performing well. This should come as a relief to fans of the Switch who might have been worried that its rise to fame might be derailed.
It’s no secret that the Nintendo Switch is on Cloud 9 right now, with the console breaking records at every turn and enthusiasm for ownership still sky high. However, even the smallest details can turn players off from a product and wonky motion controls could be a deal breaker for many. Fortunately, Kotaku and publications like it have judged that such concerns might be unwarranted.
Now, it’s worth noting that this is one game and the controls are about as straightforward as they can be. Even so, critics are still impressed by how well the characters respond to movements in order to perform three basic attacks in Arms.
For those who don’t know, Arms is basically a fighting game where players control characters who use extendable extremities to fight. Players can use both the normal controller scheme or the Joy-Con motion control and it was the latter that the reviewers focused on.
Suffice it to say, most of those who were lucky enough to test the game and the controls were surprised at how good it was. Granted, much of the excellence in the controls had a lot to do with how smart the developers were at taking advantage of the gyro-sensors, IGN notes. Whether it is punching, blocking or throwing, everything worked smoothly.
Of course, getting the hang of the controls does involve a learning curve, so players shouldn’t assume that the game will work perfectly for them without some practice. All in all, the Switch and Arms seem to perform admirably in an area where so much could have gone wrong. Players will know soon enough when the game comes out on June 16th.


France Keeps Top Health Alert as Officials Brace for Another Heatwave
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028
TrumpRx Expands Discount Drug Access With 600 Generic Medications
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 



